EUROAPI Investor Presentation H2 2024

EUROAPI is a pharmaceutical active ingredients and CDMO provider executing its Focus-27 strategic plan to concentrate on high-value, growing market segments. The company targets a 91 billion euro TAM with streamlined API Solutions and CDMO offerings aligned with sustainable and profitable growth objectives.